Humira is a type of immunosuppressant known as a tumor necrosis factor (TNF) inhibitor. It's used to treat several types of ...

In patients with RA, TNF inhibitor use during the 3 years after being diagnosed with early-stage lung, colorectal, or prostate cancer was not linked to decreased survival.

I think combination therapy is coming; it’s just a question of which combinations,’ says Arthur Kavanaugh, MD.

The following is a summary of “Advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung ...

5 The global market value for TNF inhibitor drugs was estimated to be $39.7 billion in 2024. Growing at an expected CAGR of 3.6% for the next five years, the TNF inhibitor market is expected to ...

Common options include nonsteroidal anti-inflammatory drugs (NSAIDs), tumor necrosis factor (TNF) inhibitors, and steroids. NSAIDs such as aspirin, ibuprofen (Advil, Motrin), indomethacin ...

Patients with skin disease adhering to a proper diet may experience better treatment responses and a reduced risk of adverse ...

announced that data from the Phase 2a clinical trial of its oral TNF-alpha (TNF-α) inhibitor drug candidate isomyosamine was presented last week in a podium session at the peer-reviewed 15th ...

Janus kinase (JAK) inhibitors are associated with an increased risk for lung cancer but not overall cancer among older patients in the United States with rheumatoid arthritis (RA), according to study ...